Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Squamous Non-small Cell Lung Cancer × envafolimab × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6 Thymoma 1 Squamous Non-small Cell Lung Cancer 1 Small Cell Lung Carcinoma 1 NSCLC 1 Lung Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1

Interventions

Paclitaxel 2 Carboplatin 2 tremelimumab 1 pembrolizumab 1 necitumumab 1 envafolimab 1 durvalumab 1 Nivolumab 1 Gemcitabine 1 Endostatins 1 Drug Therapy 1 Cisplatin 1 Afatinib 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05243355 2022-02-17

Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC

Qilu Hospital of Shandong University

Phase 2 Unknown

Squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡